Sage Therapeutics, Inc. (NASDAQ:SAGE) Shares Sold by Rhumbline Advisers
Rhumbline Advisers trimmed its holdings in shares of Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) by 3.4% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 84,355 shares of the biopharmaceutical company’s stock after selling 2,968 shares during the […]
Rhumbline Advisers trimmed its holdings in shares of Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) by 3.4% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 84,355 shares of the biopharmaceutical company’s stock after selling 2,968 shares during the […]
